These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 311881

  • 1. Cellular immunity in patients with epidermoid cancer of the head and neck.
    Papenhausen PR, Kukwa A, Croft CB, Borowiecki B, Silver C, Emeson EE.
    Laryngoscope; 1979 Apr; 89(4):538-49. PubMed ID: 311881
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunological status of patients in carcinoma head and neck.
    Vasenwala SM, Aziz M, Rattan A, Ahmad KN.
    Indian J Cancer; 1989 Sep; 26(3):137-44. PubMed ID: 2630426
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Transference of cell mediated immunity in patients with head and neck cancer.
    Vetto RM, Burger DR.
    Laryngoscope; 1978 Jan; 88(1 Pt 2 Suppl 8):79-82. PubMed ID: 304143
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.
    Bier J, Bitter K, Nicklisch U.
    J Maxillofac Surg; 1978 May; 6(2):75-93. PubMed ID: 353210
    [Abstract] [Full Text] [Related]

  • 9. Presence of activated T lymphocytes in peripheral blood of head and neck squamous cell carcinoma patients predicts impaired prognosis.
    Aarstad HJ, Heimdal JH, Klementsen B, Olofsson J, Ulvestad E.
    Acta Otolaryngol; 2006 Dec; 126(12):1326-33. PubMed ID: 17101596
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immune reactivity in primary carcinoma of the lung and its relation to prognosis.
    Wanebo HJ, Rao B, Miyazawa N, Martini N, Middleman MP, Oettgen HF, Beattie EJ.
    J Thorac Cardiovasc Surg; 1976 Sep; 72(3):339-50. PubMed ID: 183063
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Cellular immunity indices in benign breast tumors].
    Baisheva SA, Zhalgasbaeva GT, Kaliev IuSh, Mezinova NN.
    Vopr Onkol; 1980 Sep; 26(5):15-9. PubMed ID: 7385708
    [Abstract] [Full Text] [Related]

  • 18. Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials.
    Browder JP, Chretien PB.
    Semin Oncol; 1977 Dec; 4(4):431-9. PubMed ID: 339354
    [No Abstract] [Full Text] [Related]

  • 19. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
    Moszkowska G, Jassem J, Kondrat W, Kopacz A, Goszczyńska E.
    Arch Immunol Ther Exp (Warsz); 1980 Dec; 28(4):655-60. PubMed ID: 6970028
    [Abstract] [Full Text] [Related]

  • 20. Critical evaluation of lymphocyte functions in urological cancer patients.
    Elhilali MM, Paika KD, Brosman S, Fahey JL.
    Cancer Res; 1976 Jan; 36(1):132-7. PubMed ID: 1082369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.